All In Biotech

Drug Trial Radar · NCT04449588

Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS

A Multi-center, Open-label, Randomized Parallel Controlled Evaluation on the Efficacy and Safety of BDB-001 Injection in the Treatment of Progressive Severe COVID-19 in Phase II/III

Last checked: Nov 19, 2026Latest source record: May 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 369 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

369

Actual

Start

Jul 23, 2020

Primary completion

Mar 26, 2024

Study completion Mar 26, 2024

Sponsor

Sponsor type
Industry
Collaborators
Beijing Defengrui Biotechnology Co. Ltd
First posted
Jun 29, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multi-center, open, randomized study will evaluate the efficacy and safety of BDB-001 injection in severe COVID-19 with severe pneumonia, or acute lung injury/acute respiratory distress syndrome. Patients will be randomized to two treatment arms (Arm A: Conventional treatment + BDB-001; Arm B: Conventional treatment alone).

Conditions

  • COVID-19 Pneumonia

Interventions

  • BDB-001 InjectionDrug

    BDB-001 Injection+Conventional treatment

  • Conventional treatmentOther

    Conventional treatment only. Local guidelines should be integrated to choose the best supportive care.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to recovery of peripheral capillary oxygen saturation (SpO2) from baselineTime frame: Baseline to Day 28

Locations

12 sites in 5 countries. Site status is shown where the registry gives one.

  • Asgar Ali Hospital

    Dhaka, Bangladesh

  • Bangladesh Specialized Hospital

    Dhaka, Bangladesh

  • Southwest Hospital Chongqing

    Chongqing, Chongqing Municipality, China

  • Noble Hospital Pvt Ltd

    Nagpur, India

  • Government Medical College and Hospital

    Pune, India

  • RSUD Pasar Minggu(Pasar Minggu General Hospital)

    Jakarta, Indonesia

  • RSUP Persahabatan(Persahabatan General Hospital)

    Jakarta, Indonesia

  • RSUD Cengkareng(Cengkareng General Hospital)

    Jakarta, Jakrata, Indonesia

  • Hospital Universitario 12 De Octubre

    Madrid, Spain

  • Hospital Universitario Clínico San Carlos

    Madrid, Spain

  • Hospital Universitario de la Princesa

    Madrid, Spain

  • Hospital Universitario Fundación Díaz

    Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.